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Once again, I am pleased to wish all our authors
and readers a happy, productive and peaceful
New Year on behalf of the CMI Editorial Team
and the Society. The forthcoming year will be a
year of transition for CMI, as the current Editorial
Team completes its 5-year term of office with the
December 2008 issue. It is my pleasure to
announce that the new Editor-in-Chief will be
Professor Didier Raoult (Marseille, France). Pro-
fessor Raoult and his team will start to handle the
assessment of new submissions with effect from
April 2008, and will be responsible for the content
of the January 2009 issue onwards. We hope that
the transition between the two editorial teams will
be as smooth as possible, but we ask authors for
their understanding if some minor delays occur
during the transition process.
There will be some changes in the editorial
process, and probably in the appearance and
content of the journal, for 2009. However, one
change that is being introduced in the immediate
short-term concerns a requirement for greater
transparency regarding potential conflicts of
interest among authors of published manuscripts.
As before, all results presented previously at a
scientific meeting or in another public context
must be acknowledged, giving the context, loca-
tion and date of presentation. In addition, sources
of funding, as well as a general statement dis-
closing, or excluding, any degree of commercial
interest or potential dual interest of any nature,
must be included. Specifically, CMI will now
require acknowledgment of funding or support
from, employment by, or possession of shares in
an enterprise that may in any way profit from or
be affected by the results of the study or the
conclusions of the article, as well as details of any
other relationships or associations, financial or of
another nature, that may constitute a conflict of
interest. Such relationships might include direct
or indirect support for a study (either financial or
in terms of consumables), receipt of a travel grant,
membership of a panel of speakers, invitation to
attend a conference, etc. As a minimum, all such
relationships in at least the 3-year period imme-
diately preceding submission of a manuscript
must be declared. If no potential conflicting
interest exists, a statement to that effect should
be included for publication. If no statement is
provided, the following text will be included in
the Acknowledgements section during the edito-
rial process: No information has been provided by the
authors concerning the existence or absence of con-
flicting or dual interests. We believe that this
approach will bring CMI into line with other
reputable scientific journals. Our purpose is not to
hinder collaboration or relationships with com-
mercial organisations, but simply to provide the
maximum possible transparency to the reader
concerning the extent and possible ramifications
of such links.
Finally, as I come towards the end of my term
as Editor-in-Chief, I would like to thank the entire
Editorial Team for their support and hard work in
producing CMI during the past 5 years. The
numbers of submissions, as well as the CMI
impact factor, have almost tripled during this
period, but the time from acceptance to publica-
tion has halved. We have also successfully intro-
duced the online submission and manuscript
handling system, and authors are seeing the
benefits of ‘online early’, in which accepted
manuscripts are made available to the scientific
community on the internet within a few days of
the proofs being approved for publication. While
success creates some difficulties of its own, I hope
that you will feel that CMI has developed in a
positive manner during the past 5 years. It has
been a personal honour to play a role in this
development process, and I have greatly enjoyed
meeting and corresponding with many of our
authors and readers. Thank you for your support.
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